| 摘要 |
A pharmaceutical formulation containing: a polypeptide selected from a group containing insulin, an insulin metabolite, an insulin analog, an insulin derivative or combinations thereof; a surfactant or combinations of several surfactants; optionally, a preservative or combinations of several preservatives, and; optionally, an isotonizing agent, buffers or further excipients or combinations thereof is disclosed, wherein the pharmaceutical formulation does not contain any zinc or only a small quantity of zinc. |
